Osteoprotective action of low-salt diet requires myeloid cell-derived NFAT5

Dietary salt consumption leads to cutaneous Na+ storage and is associated with various disorders, including osteopenia. Here, we explore the impact of Na+ and the osmoprotective transcription factor nuclear factor of activated T cell 5 (NFAT5) on bone density and osteoclastogenesis. Compared with tr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JCI insight 2019-12, Vol.4 (23)
Hauptverfasser: Schröder, Agnes, Neubert, Patrick, Titze, Jens, Bozec, Aline, Neuhofer, Wolfgang, Proff, Peter, Kirschneck, Christian, Jantsch, Jonathan
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 23
container_start_page
container_title JCI insight
container_volume 4
creator Schröder, Agnes
Neubert, Patrick
Titze, Jens
Bozec, Aline
Neuhofer, Wolfgang
Proff, Peter
Kirschneck, Christian
Jantsch, Jonathan
description Dietary salt consumption leads to cutaneous Na+ storage and is associated with various disorders, including osteopenia. Here, we explore the impact of Na+ and the osmoprotective transcription factor nuclear factor of activated T cell 5 (NFAT5) on bone density and osteoclastogenesis. Compared with treatment of mice with high-salt diet, low-salt diet (LSD) increased bone density, decreased osteoclast numbers, and elevated Na+ content and Nfat5 levels in the BM. This response to LSD was dependent on NFAT5 expressed in myeloid cells. Simulating in vivo findings, we exposed osteoclast precursors and osteoblasts to elevated Na+ content (high-salt conditions; HS¢), resulting in increased NFAT5 binding to the promotor region of RANKL decoy receptor osteoprotegerin (OPG). These data not only demonstrate that NFAT5 in myeloid cells determines the Na+ content in BM, but that NFAT5 is able to govern the expression of the osteoprotective gene OPG. This provides insights into mechanisms of Na+-induced cessation of osteoclastogenesis and offers potentially new targets for treating salt-induced osteopenia.
doi_str_mv 10.1172/jci.insight.127868
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6962031</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2322142783</sourcerecordid><originalsourceid>FETCH-LOGICAL-c402t-89f0ac5b37ae7e8011869015908a6d6660e90eaa5e81d4066e58973540f8f6553</originalsourceid><addsrcrecordid>eNpVUcFOwzAMjRCIIdgPcEA9culwkiZNL0hoYoBAcBnnKGtdFtQ2I0mH9vd02pjg9CzZ79l-j5BLChNKc3bzWdqJ7YL9WMYJZbmS6oicMZ4XKc9BHf-pR2QcwicA0DxjINQpGXGqgBYgz8jzW4joVt5FLKNdY2IGcF3i6qRx32kwTUwqizHx-NVbjyFpN9g4WyUlNk1aoR9IVfI6u5uLC3JSmybgeI_n5H12P58-pi9vD0_Tu5e0zIDFVBU1mFIseG4wx-EQqmQBVBSgjKyklIAFoDECFa0ykBKFKnIuMqhVLYXg5-R2p7vqFy1WJXbRm0avvG2N32hnrP7f6exSf7i1loVkwOkgcL0X8O6rxxB1a8P2H9Oh64NmnDGaDabyYZTtRkvvQvBYH9ZQ0Nsg9BCE3gehd0EMpKu_Bx4ov7bzH66bhy8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2322142783</pqid></control><display><type>article</type><title>Osteoprotective action of low-salt diet requires myeloid cell-derived NFAT5</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Schröder, Agnes ; Neubert, Patrick ; Titze, Jens ; Bozec, Aline ; Neuhofer, Wolfgang ; Proff, Peter ; Kirschneck, Christian ; Jantsch, Jonathan</creator><creatorcontrib>Schröder, Agnes ; Neubert, Patrick ; Titze, Jens ; Bozec, Aline ; Neuhofer, Wolfgang ; Proff, Peter ; Kirschneck, Christian ; Jantsch, Jonathan</creatorcontrib><description>Dietary salt consumption leads to cutaneous Na+ storage and is associated with various disorders, including osteopenia. Here, we explore the impact of Na+ and the osmoprotective transcription factor nuclear factor of activated T cell 5 (NFAT5) on bone density and osteoclastogenesis. Compared with treatment of mice with high-salt diet, low-salt diet (LSD) increased bone density, decreased osteoclast numbers, and elevated Na+ content and Nfat5 levels in the BM. This response to LSD was dependent on NFAT5 expressed in myeloid cells. Simulating in vivo findings, we exposed osteoclast precursors and osteoblasts to elevated Na+ content (high-salt conditions; HS¢), resulting in increased NFAT5 binding to the promotor region of RANKL decoy receptor osteoprotegerin (OPG). These data not only demonstrate that NFAT5 in myeloid cells determines the Na+ content in BM, but that NFAT5 is able to govern the expression of the osteoprotective gene OPG. This provides insights into mechanisms of Na+-induced cessation of osteoclastogenesis and offers potentially new targets for treating salt-induced osteopenia.</description><identifier>ISSN: 2379-3708</identifier><identifier>EISSN: 2379-3708</identifier><identifier>DOI: 10.1172/jci.insight.127868</identifier><identifier>PMID: 31801906</identifier><language>eng</language><publisher>United States: American Society for Clinical Investigation</publisher><ispartof>JCI insight, 2019-12, Vol.4 (23)</ispartof><rights>2019 American Society for Clinical Investigation 2019 American Society for Clinical Investigation</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c402t-89f0ac5b37ae7e8011869015908a6d6660e90eaa5e81d4066e58973540f8f6553</citedby><cites>FETCH-LOGICAL-c402t-89f0ac5b37ae7e8011869015908a6d6660e90eaa5e81d4066e58973540f8f6553</cites><orcidid>0000-0001-8463-8404 ; 0000-0001-9473-8724 ; 0000-0001-6010-9831</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962031/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962031/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31801906$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schröder, Agnes</creatorcontrib><creatorcontrib>Neubert, Patrick</creatorcontrib><creatorcontrib>Titze, Jens</creatorcontrib><creatorcontrib>Bozec, Aline</creatorcontrib><creatorcontrib>Neuhofer, Wolfgang</creatorcontrib><creatorcontrib>Proff, Peter</creatorcontrib><creatorcontrib>Kirschneck, Christian</creatorcontrib><creatorcontrib>Jantsch, Jonathan</creatorcontrib><title>Osteoprotective action of low-salt diet requires myeloid cell-derived NFAT5</title><title>JCI insight</title><addtitle>JCI Insight</addtitle><description>Dietary salt consumption leads to cutaneous Na+ storage and is associated with various disorders, including osteopenia. Here, we explore the impact of Na+ and the osmoprotective transcription factor nuclear factor of activated T cell 5 (NFAT5) on bone density and osteoclastogenesis. Compared with treatment of mice with high-salt diet, low-salt diet (LSD) increased bone density, decreased osteoclast numbers, and elevated Na+ content and Nfat5 levels in the BM. This response to LSD was dependent on NFAT5 expressed in myeloid cells. Simulating in vivo findings, we exposed osteoclast precursors and osteoblasts to elevated Na+ content (high-salt conditions; HS¢), resulting in increased NFAT5 binding to the promotor region of RANKL decoy receptor osteoprotegerin (OPG). These data not only demonstrate that NFAT5 in myeloid cells determines the Na+ content in BM, but that NFAT5 is able to govern the expression of the osteoprotective gene OPG. This provides insights into mechanisms of Na+-induced cessation of osteoclastogenesis and offers potentially new targets for treating salt-induced osteopenia.</description><issn>2379-3708</issn><issn>2379-3708</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNpVUcFOwzAMjRCIIdgPcEA9culwkiZNL0hoYoBAcBnnKGtdFtQ2I0mH9vd02pjg9CzZ79l-j5BLChNKc3bzWdqJ7YL9WMYJZbmS6oicMZ4XKc9BHf-pR2QcwicA0DxjINQpGXGqgBYgz8jzW4joVt5FLKNdY2IGcF3i6qRx32kwTUwqizHx-NVbjyFpN9g4WyUlNk1aoR9IVfI6u5uLC3JSmybgeI_n5H12P58-pi9vD0_Tu5e0zIDFVBU1mFIseG4wx-EQqmQBVBSgjKyklIAFoDECFa0ykBKFKnIuMqhVLYXg5-R2p7vqFy1WJXbRm0avvG2N32hnrP7f6exSf7i1loVkwOkgcL0X8O6rxxB1a8P2H9Oh64NmnDGaDabyYZTtRkvvQvBYH9ZQ0Nsg9BCE3gehd0EMpKu_Bx4ov7bzH66bhy8</recordid><startdate>20191205</startdate><enddate>20191205</enddate><creator>Schröder, Agnes</creator><creator>Neubert, Patrick</creator><creator>Titze, Jens</creator><creator>Bozec, Aline</creator><creator>Neuhofer, Wolfgang</creator><creator>Proff, Peter</creator><creator>Kirschneck, Christian</creator><creator>Jantsch, Jonathan</creator><general>American Society for Clinical Investigation</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8463-8404</orcidid><orcidid>https://orcid.org/0000-0001-9473-8724</orcidid><orcidid>https://orcid.org/0000-0001-6010-9831</orcidid></search><sort><creationdate>20191205</creationdate><title>Osteoprotective action of low-salt diet requires myeloid cell-derived NFAT5</title><author>Schröder, Agnes ; Neubert, Patrick ; Titze, Jens ; Bozec, Aline ; Neuhofer, Wolfgang ; Proff, Peter ; Kirschneck, Christian ; Jantsch, Jonathan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c402t-89f0ac5b37ae7e8011869015908a6d6660e90eaa5e81d4066e58973540f8f6553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schröder, Agnes</creatorcontrib><creatorcontrib>Neubert, Patrick</creatorcontrib><creatorcontrib>Titze, Jens</creatorcontrib><creatorcontrib>Bozec, Aline</creatorcontrib><creatorcontrib>Neuhofer, Wolfgang</creatorcontrib><creatorcontrib>Proff, Peter</creatorcontrib><creatorcontrib>Kirschneck, Christian</creatorcontrib><creatorcontrib>Jantsch, Jonathan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>JCI insight</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schröder, Agnes</au><au>Neubert, Patrick</au><au>Titze, Jens</au><au>Bozec, Aline</au><au>Neuhofer, Wolfgang</au><au>Proff, Peter</au><au>Kirschneck, Christian</au><au>Jantsch, Jonathan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Osteoprotective action of low-salt diet requires myeloid cell-derived NFAT5</atitle><jtitle>JCI insight</jtitle><addtitle>JCI Insight</addtitle><date>2019-12-05</date><risdate>2019</risdate><volume>4</volume><issue>23</issue><issn>2379-3708</issn><eissn>2379-3708</eissn><abstract>Dietary salt consumption leads to cutaneous Na+ storage and is associated with various disorders, including osteopenia. Here, we explore the impact of Na+ and the osmoprotective transcription factor nuclear factor of activated T cell 5 (NFAT5) on bone density and osteoclastogenesis. Compared with treatment of mice with high-salt diet, low-salt diet (LSD) increased bone density, decreased osteoclast numbers, and elevated Na+ content and Nfat5 levels in the BM. This response to LSD was dependent on NFAT5 expressed in myeloid cells. Simulating in vivo findings, we exposed osteoclast precursors and osteoblasts to elevated Na+ content (high-salt conditions; HS¢), resulting in increased NFAT5 binding to the promotor region of RANKL decoy receptor osteoprotegerin (OPG). These data not only demonstrate that NFAT5 in myeloid cells determines the Na+ content in BM, but that NFAT5 is able to govern the expression of the osteoprotective gene OPG. This provides insights into mechanisms of Na+-induced cessation of osteoclastogenesis and offers potentially new targets for treating salt-induced osteopenia.</abstract><cop>United States</cop><pub>American Society for Clinical Investigation</pub><pmid>31801906</pmid><doi>10.1172/jci.insight.127868</doi><orcidid>https://orcid.org/0000-0001-8463-8404</orcidid><orcidid>https://orcid.org/0000-0001-9473-8724</orcidid><orcidid>https://orcid.org/0000-0001-6010-9831</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2379-3708
ispartof JCI insight, 2019-12, Vol.4 (23)
issn 2379-3708
2379-3708
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6962031
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
title Osteoprotective action of low-salt diet requires myeloid cell-derived NFAT5
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T11%3A08%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Osteoprotective%20action%20of%20low-salt%20diet%20requires%20myeloid%20cell-derived%20NFAT5&rft.jtitle=JCI%20insight&rft.au=Schr%C3%B6der,%20Agnes&rft.date=2019-12-05&rft.volume=4&rft.issue=23&rft.issn=2379-3708&rft.eissn=2379-3708&rft_id=info:doi/10.1172/jci.insight.127868&rft_dat=%3Cproquest_pubme%3E2322142783%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2322142783&rft_id=info:pmid/31801906&rfr_iscdi=true